APPENDIX D Quality Ratings for Psychotherapies and Efficacy Data for Medications PracticeWise “Evidence-Based Child and Adolescent Psychosocial Interventions” This report is intended to guide practitioners, educators, youth, and families in developing appropriate plans using psychosocial interventions. It was created using the PracticeWise Evidence-Based Services (PWEBS) database, available at www.practicewise.com. Please check the American Academy of Pediatrics (AAP) mental health Web site (www.aap.org/mentalhealth) for updates. Please note that this chart represents an independent analysis by PracticeWise and should not be construed as endorsement by the AAP. For an explanation of PracticeWise determination of evidence/level, please visit www.practicewise.com/aap. Safety and Efficacy Studies Supporting Group 1 Medications (Table D-1) As a proxy for the magnitude of effect, the rate of responders taking the active drug and placebo is listed. It is important to note that a responder is not the same as a remitter. A patient who remits no longer meets diagnostic criteria and has no or very mild residual symptoms, whereas a responder generally meets a severity criterion of “much better” or “very much better” but may still have mild to moderate symptoms. Thus, a remitter is generally more improved than a responder. The last column notes whether ratings were done by “independent evaluators” (IEs). An IE is a rater who is not involved in data collection other than to conduct blinded symptom severity
Previous Page Next Page